Associated Capital Group, Inc. AC Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001437749-25-015833
cik 1642122
name ASSOCIATED CAPITAL GROUP, INC.
sic 6211
countryba US
stprba CT
cityba GREENWICH
zipba 06830
bas1 191 MASON STREET
bas2
baph 914-921-5135
countryma US
stprma CT
cityma GREENWICH
zipma 06830
mas1 191 MASON STREET
mas2
countryinc US
stprinc DE
ein 000000000
former GABELLI SECURITIES GROUP, INC.
changed 20150512
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250509
accepted 2025-05-09 16:56:00.0
prevrpt 0
detail 1
instance ac20250331_10q_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001437749-25-015833 20250331 Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities -15910000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Cash And Cash Equivalents At Carrying Value 308729000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 347057000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Equity Method Investments -20549000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 196557000.0000 USD 0 us-gaap/2025 Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 8290000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 11000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 8028000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 8028000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20240331 Gain Loss On Investments 16794000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Income Tax Expense Benefit 3798000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Accounts Receivable -3470000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Investment Advisory Fees Receivable 1076000.0000 USD 0 0001437749-25-015833
0001437749-25-015833 20250331 Liabilities And Stockholders Equity 933257000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Liabilities And Stockholders Equity 924546000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Net Cash Provided By Used In Financing Activities -4306000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Net Cash Provided By Used In Operating Activities -8141000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Net Income Loss Attributable To Noncontrolling Interest 36000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 0.0000 USD 1 0001437749-25-015833 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 0.0000 USD 1 0001437749-25-015833 Equity Components= Common Stock;
0001437749-25-015833 20250331 Noncash Contribution Expense 284000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Operating Expenses 7417000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Operating Income Loss -366000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Payables To Broker Dealers And Clearing Organizations 5491000.0000 USD 0 srt/2025
0001437749-25-015833 20240331 Payments To Minority Shareholders 360000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2025
0001437749-25-015833 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2025
0001437749-25-015833 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2025
0001437749-25-015833 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 2907000.0000 USD 1 us-gaap/2025 Product Or Service= Investment Advice;
0001437749-25-015833 20250331 Stockholders Equity 898958000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 999047000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 48231000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 999047000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 999047000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 898958000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 53478000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20241231 Cash And Cash Equivalents At Carrying Value 9560000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Earnings Per Share Basic 0.3600 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities -14962000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Assets 935289000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Assets 72400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Voting Interest Entities;
0001437749-25-015833 20240331 Cash And Cash Equivalents At Carrying Value 7663000.0000 USD 0 us-gaap/2025 Accounts Notes Loans And Financing Receivable By Receivable Type= Receivables From Brokers;
0001437749-25-015833 20241231 Cash And Cash Equivalents At Carrying Value 289991000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 317355000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20240331 Common Stock Shares Outstanding 21420000.0000 shares 0 us-gaap/2025
0001437749-25-015833 20241231 Common Stock Shares Outstanding 18950571.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20250331 Common Stock Shares Outstanding 2194902.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20240331 Deferred Income Tax Expense Benefit 2124000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Deferred Income Tax Expense Benefit 1617000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 139303000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 43000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 1010000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 16920000.0000 USD 0 us-gaap/2025 Ownership= Gamco Investors Inc;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 8436000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 8236000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 200000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 688000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20241231 Goodwill 3400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Gabelli Company Investment Advisers Inc;
0001437749-25-015833 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 17655000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Accrued Income Taxes Payable 0.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Income Taxes Receivable 94000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Interest Paid Net 83000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Investment Advisory Fees Receivable 4142000.0000 USD 0 0001437749-25-015833
0001437749-25-015833 20241231 Investment Advisory Fees Receivable 4142000.0000 USD 0 0001437749-25-015833 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Liabilities 1900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Voting Interest Entities;
0001437749-25-015833 20250331 Liabilities And Stockholders Equity 8711000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Minority Interest Decrease From Redemptions 360000.0000 USD 1 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Net Income Loss Attributable To Noncontrolling Interest 100000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 0.0000 USD 1 0001437749-25-015833 Equity Components= Common Stock;
0001437749-25-015833 20250331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 0.0000 USD 1 0001437749-25-015833 Equity Components= Treasury Stock Common;
0001437749-25-015833 20240331 Operating Expenses 7981000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Other Receivables 676000.0000 USD 0 us-gaap/2025 Related Party Transactions By Related Party= Affiliated Entity;
0001437749-25-015833 20250331 Payments For Repurchase Of Common Stock 1417000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax -109000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 3120000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 USD 1 us-gaap/2025 Product Or Service= Performance Based Advisory Fees;
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1680000.0000 USD 1 us-gaap/2025 Product Or Service= Sub Advisory Fees;
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1959000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Shareholderdesignated Contribution 31000.0000 USD 1 0001437749-25-015833
0001437749-25-015833 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 916850000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20250331 Treasury Stock Value Acquired Cost Method 1417000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Weighted Average Number Of Shares Outstanding Basic 21166000.0000 shares 1 us-gaap/2025
0001437749-25-015833 20241231 Assets 7787000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Assets 74700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Voting Interest Entities;
0001437749-25-015833 20250331 Cash And Cash Equivalents At Carrying Value 12881000.0000 USD 0 us-gaap/2025 Accounts Notes Loans And Financing Receivable By Receivable Type= Receivables From Brokers;
0001437749-25-015833 20250331 Cash And Cash Equivalents At Carrying Value 1000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001437749-25-015833 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20250331 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20241231 Common Stock Shares Issued 6641601.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20241231 Common Stock Value 19000.0000 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20250331 Employee Related Liabilities Current And Noncurrent 5900000.0000 USD 0 us-gaap/2025 Award Type= Phantom Restricted Stock Award;
0001437749-25-015833 20241231 Equity Method Investments 139988000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 193668000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 1168000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 42000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 115000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 146000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 189000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 8104000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 688000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 726000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Gain Loss On Investments 10892000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Income Taxes Paid Net 66000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Accounts Receivable -3066000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Accrued Income Taxes Payable 1723000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Payables To Broker Dealers 1873000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Payables To Broker Dealers -233000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Interest Expense Nonoperating 45000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Investment Income Interest And Dividend 5018000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Investment Owned At Fair Value 225333000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Net Cash Provided By Used In Investing Activities 1220000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Operating Income Loss -4970000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Operating Income Loss -5288000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Other Operating Income Expense Net -2179000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Other Operating Income Expense Net -1866000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Payments To Acquire Available For Sale Securities Debt 3000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Payments To Minority Shareholders 10000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2025
0001437749-25-015833 20240331 Proceeds From Sale Of Available For Sale Securities Debt 2711000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 5592000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 5592000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 304000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001437749-25-015833 20240331 Shareholderdesignated Contribution 69000.0000 USD 1 0001437749-25-015833
0001437749-25-015833 20241231 Stockholders Equity 892706000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 892706000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5682000.0000 USD 0 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20241231 Trading Securities Debt 68299000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Trading Securities Debt 68299000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 63956000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 63956000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Treasury Stock Common Value 153592000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20250331 Cash And Cash Equivalents At Carrying Value 293857000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Commitments And Contingencies USD 0 us-gaap/2025
0001437749-25-015833 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20241231 Common Stock Shares Issued 19196792.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20241231 Common Stock Value 6000.0000 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20250331 Common Stock Value 19000.0000 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20240331 Debt And Equity Securities Unrealized Gain Loss 12626000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Equity Method Investments -21021000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Equity Method Investments 162572000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 210868000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 630000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 15599000.0000 USD 0 us-gaap/2025 Ownership= Gamco Investors Inc;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 38000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 10546000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Income Tax Receivable 6021000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Income Tax Receivable 3310000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Due From Affiliates Current 9000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Other Operating Assets -2652000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Interest Expense Nonoperating 83000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Investment Owned At Fair Value 165515000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Investment Owned At Fair Value -54907000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Investment Owned At Fair Value 220422000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Investment Owned At Fair Value 169336000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Labor And Related Expense 4448000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Minority Interest Decrease From Redemptions 10000.0000 USD 1 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20240331 Net Income Loss Attributable To Noncontrolling Interest 36000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 13821000.0000 USD 1 0001437749-25-015833
0001437749-25-015833 20250331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 100000.0000 USD 1 0001437749-25-015833 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20250331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 7669000.0000 USD 1 0001437749-25-015833 Equity Components= Retained Earnings;
0001437749-25-015833 20240331 Nonoperating Income Expense 22447000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Operating Income Loss -4607000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Other Assets 19650000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Payments To Acquire Available For Sale Securities Debt 3953000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2025
0001437749-25-015833 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2025
0001437749-25-015833 20240331 Profit Loss 13857000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Profit Loss 7769000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Receivable From Brokerdealer And Clearing Organization Net Of Cash Withheld For Real Estate 27634000.0000 USD 0 0001437749-25-015833
0001437749-25-015833 20250331 Receivable From Brokerdealer And Clearing Organization Net Of Cash Withheld For Real Estate 25458000.0000 USD 0 0001437749-25-015833
0001437749-25-015833 20250331 Retained Earnings Accumulated Deficit 53478000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 104000.0000 USD 1 us-gaap/2025 Product Or Service= Financial Service Other;
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 104000.0000 USD 1 us-gaap/2025 Product Or Service= Other Miscellaneous Revenues;
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 125000.0000 USD 1 us-gaap/2025 Product Or Service= Financial Service Other;
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 125000.0000 USD 1 us-gaap/2025 Product Or Service= Other Miscellaneous Revenues;
0001437749-25-015833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -140328000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20241231 Trading Securities Debt 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 63956000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Treasury Stock Common Shares 4446699.0000 shares 0 us-gaap/2025
0001437749-25-015833 20240331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20250331 Treasury Stock Value Acquired Cost Method 1417000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20250331 Accrued Liabilities And Other Liabilities 2149000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Assets 927502000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Assets 933257000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Cash And Cash Equivalents At Carrying Value 118000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001437749-25-015833 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 340983000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -6074000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -8348000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20240331 Debt And Equity Securities Realized Gain Loss 2147000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Equity Method Investments 160537000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 59737000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 137798000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 206426000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 473000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 2026000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 209011000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 209011000.0000 USD 0 us-gaap/2025 Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 8247000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 8236000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 8754000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Goodwill 3519000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Income Loss From Equity Method Investments 3850000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Accrued Liabilities And Other Operating Liabilities -2659000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Contributions To Partnerships 4839000.0000 USD 1 0001437749-25-015833
0001437749-25-015833 20250331 Increase Decrease In Other Operating Assets -1205000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Investment Advisory Fees Receivable 0.0000 USD 0 0001437749-25-015833 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Investment Owned At Fair Value 169336000.0000 USD 0 us-gaap/2025 Investment Issuer Affiliation= Investment Affiliated Issuer;
0001437749-25-015833 20240331 Labor And Related Expense 3820000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20240331 Net Cash Provided By Used In Investing Activities -663000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss 13821000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss 13821000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Net Income Loss 7669000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 7669000.0000 USD 1 0001437749-25-015833
0001437749-25-015833 20250331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 0.0000 USD 1 0001437749-25-015833 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20240331 Noncash Contribution Expense 1279000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Nonoperating Income Expense 178000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Nonoperating Income Expense 15834000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Additional Paid In Capital 999047000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20250331 Common Stock Shares Issued 6641601.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20241231 Common Stock Shares Outstanding 2233920.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20250331 Common Stock Shares Outstanding 18950571.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20240331 Equity Method Investment Dividends Or Distributions 4300000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 199040000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 115000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 1315000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 1227000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20240331 Income Loss From Equity Method Investments 2699000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Debt Securities Trading 3762000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Due From Affiliates Current 40000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Interest Paid Net 45000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Investment Advisory Fees Receivable 1077000.0000 USD 0 0001437749-25-015833 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Liabilities 36991000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Liabilities 28617000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Liabilities And Stockholders Equity 7787000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Liabilities And Stockholders Equity 927502000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Management Fee Expense 1103000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20250331 Net Income Loss Attributable To Noncontrolling Interest 100000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 36000.0000 USD 1 0001437749-25-015833 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20240331 Nonoperating Income Expense 22625000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Operating Income Loss -363000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Operating Income Loss -4922000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 579000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Restricted Cash And Cash Equivalents 10617000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Retained Earnings Accumulated Deficit 45809000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 937000.0000 USD 1 us-gaap/2025 Product Or Service= Sub Advisory Fees;
0001437749-25-015833 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -144274000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 45809000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 898958000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -153592000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20241231 Treasury Stock Common Shares 4407681.0000 shares 0 us-gaap/2025
0001437749-25-015833 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20241231 Additional Paid In Capital 999047000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Assets 924546000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20240331 Cash And Cash Equivalents At Carrying Value 13334000.0000 USD 0 us-gaap/2025 Accounts Notes Loans And Financing Receivable By Receivable Type= Cash Held For Real Estate Purchase;
0001437749-25-015833 20241231 Cash And Cash Equivalents At Carrying Value 299551000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Cash And Cash Equivalents At Carrying Value 0.0000 USD 0 us-gaap/2025 Accounts Notes Loans And Financing Receivable By Receivable Type= Cash Held For Real Estate Purchase;
0001437749-25-015833 20250331 Cash And Cash Equivalents At Carrying Value 3084000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 340983000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 325703000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0001437749-25-015833 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20250331 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20250331 Common Stock Shares Issued 19196792.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001437749-25-015833 20250331 Common Stock Value 6000.0000 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001437749-25-015833 20250331 Debt And Equity Securities Realized Gain Loss 2343000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Depreciation Depletion And Amortization 89000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Earnings Per Share Basic 0.6400 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 854000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 196557000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 1315000.0000 USD 0 us-gaap/2025 Financial Instrument= Mutual Fund;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 73070000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 1227000.0000 USD 0 us-gaap/2025 Financial Instrument= Mutual Fund;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 189000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 8436000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 650000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 8754000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20250331 Income Tax Expense Benefit 2777000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Accrued Liabilities And Other Operating Liabilities -3168000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Contributions To Partnerships 1663000.0000 USD 1 0001437749-25-015833
0001437749-25-015833 20250331 Increase Decrease In Debt Securities Trading 7687000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Employee Related Liabilities -3624000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Employee Related Liabilities -5291000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Income Taxes Receivable -1094000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Investment Advisory Fees Receivable -1000.0000 USD 0 0001437749-25-015833 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Liabilities 2900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Voting Interest Entities;
0001437749-25-015833 20240331 Management Fee Expense 1982000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Net Cash Provided By Used In Financing Activities -1427000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Cash Provided By Used In Operating Activities -1105000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Net Income Loss 7669000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Nonoperating Income Expense 987000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Profit Loss 100000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Profit Loss 7669000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 5682000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 5400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Voting Interest Entities;
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1227000.0000 USD 1 us-gaap/2025 Product Or Service= Asset Based Advisory Fees;
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1057000.0000 USD 1 us-gaap/2025 Product Or Service= Asset Based Advisory Fees;
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2004000.0000 USD 1 us-gaap/2025 Product Or Service= Investment Advice;
0001437749-25-015833 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5779000.0000 USD 0 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 62052000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Trading Securities Debt 64320000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Trading Securities Debt 68299000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20240331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001437749-25-015833 20241231 Accrued Liabilities And Other Liabilities 5317000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Assets 8711000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Cash And Cash Equivalents At Carrying Value 290773000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 317355000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Common Stock Shares Outstanding 21145000.0000 shares 0 us-gaap/2025
0001437749-25-015833 20250331 Debt And Equity Securities Unrealized Gain Loss 2462000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Depreciation Depletion And Amortization 90000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Employee Related Liabilities Current And Noncurrent 17747000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Employee Related Liabilities Current And Noncurrent 4800000.0000 USD 0 us-gaap/2025 Award Type= Phantom Restricted Stock Award;
0001437749-25-015833 20250331 Employee Related Liabilities Current And Noncurrent 12456000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Equity Method Investment Dividends Or Distributions 3950000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Equity Method Investments 141551000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 10473000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 1315000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 2035000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Equity Securities Fv Ni Current And Noncurrent 1168000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Investments;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 10635000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 1227000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mutual Fund;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 559000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20250331 Equity Securities Fv Ni Current And Noncurrent 630000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Investments;
0001437749-25-015833 20241231 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 8066000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001437749-25-015833 20250331 Financial Instruments Sold Not Yet Purchased At Fair Value 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0001437749-25-015833 20241231 Goodwill 3519000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Goodwill 3400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Gabelli Company Investment Advisers Inc;
0001437749-25-015833 20240331 Income Taxes Paid Net 30000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Increase Decrease In Brokerage Receivables 14000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Increase Decrease In Brokerage Receivables 478000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Investment Income Interest And Dividend 5983000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20241231 Investment Owned At Fair Value 165515000.0000 USD 0 us-gaap/2025 Investment Issuer Affiliation= Investment Affiliated Issuer;
0001437749-25-015833 20250331 Investment Owned At Fair Value -55997000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Liabilities And Stockholders Equity 935289000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 13821000.0000 USD 1 0001437749-25-015833 Equity Components= Retained Earnings;
0001437749-25-015833 20240331 Net Income Loss Including Portion Attributable To Noncontrolling Interests 0.0000 USD 1 0001437749-25-015833 Equity Components= Treasury Stock Common;
0001437749-25-015833 20250331 Nonoperating Income Expense 14847000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Other Assets 20944000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20250331 Payables To Broker Dealers And Clearing Organizations 5258000.0000 USD 0 srt/2025
0001437749-25-015833 20240331 Payments For Repurchase Of Common Stock 3946000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Profit Loss 36000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 5682000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Restricted Cash And Cash Equivalents 11257000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Revenue From Contract With Customer Excluding Assessed Tax 3011000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2129000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 170000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 25000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6103000.0000 USD 0 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 25000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 892706000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 25000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5592000.0000 USD 0 us-gaap/2025 Equity Components= Redeemable Noncontrolling Interests;
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Trading Securities Debt 3979000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entities;
0001437749-25-015833 20241231 Trading Securities Debt 68299000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 63956000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20241231 Treasury Stock Common Value 152175000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Treasury Stock Value Acquired Cost Method 3946000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20240331 Weighted Average Number Of Shares Outstanding Basic 21500000.0000 shares 1 us-gaap/2025
0001437749-25-015833 20241231 Other Receivables 636000.0000 USD 0 us-gaap/2025 Related Party Transactions By Related Party= Affiliated Entity;
0001437749-25-015833 20250331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 610000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20250331 Proceeds From Sale Of Available For Sale Securities Debt 613000.0000 USD 1 us-gaap/2025
0001437749-25-015833 20240331 Profit Loss 13821000.0000 USD 1 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Consolidated Entities;
0001437749-25-015833 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 307000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001437749-25-015833 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 5300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Voting Interest Entities;
0001437749-25-015833 20250331 Revenue From Contract With Customer Excluding Assessed Tax 10000.0000 USD 1 us-gaap/2025 Product Or Service= Performance Based Advisory Fees;
0001437749-25-015833 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 906975000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -152175000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 999047000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001437749-25-015833 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 25000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001437749-25-015833 20241231 Trading Securities Debt 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Bill Securities;
0001437749-25-015833 20250331 Trading Securities Debt 63956000.0000 USD 0 us-gaap/2025
0001437749-25-015833 20240331 Treasury Stock Value Acquired Cost Method 3946000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Cash And Cash Equivalents At Carrying Value us-gaap/2025 0 0 monetary I D Cash and Cash Equivalent Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Receivable From Brokerdealer And Clearing Organization Net Of Cash Withheld For Real Estate 0001437749-25-015833 1 0 monetary I D ac_ReceivableFromBrokerdealerAndClearingOrganizationNetOfCashWithheldForRealEstate Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Increase Decrease In Debt Securities Trading us-gaap/2025 0 0 monetary D C Increase (Decrease) in Debt Securities, Trading Amount of increase (decrease) of investment in debt security measured at fair value with change in fair value recognized in net income (trading).
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2025 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Additional Paid In Capital us-gaap/2025 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Profit Loss us-gaap/2025 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Debt And Equity Securities Realized Gain Loss us-gaap/2025 0 0 monetary D C Debt and Equity Securities, Realized Gain (Loss) Amount of realized gain (loss) on investment in debt and equity securities.
Minority Interest Decrease From Redemptions us-gaap/2025 0 0 monetary D D Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).
Operating Income Loss us-gaap/2025 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Depreciation Depletion And Amortization us-gaap/2025 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Debt And Equity Securities Unrealized Gain Loss us-gaap/2025 0 0 monetary D C Debt and Equity Securities, Unrealized Gain (Loss) Amount of unrealized gain (loss) on investment in debt and equity securities.
Management Fee Expense us-gaap/2025 0 0 monetary D D Management Fee Expense Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.
Operating Expenses us-gaap/2025 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Payments For Repurchase Of Common Stock us-gaap/2025 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2025 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Shareholderdesignated Contribution 0001437749-25-015833 1 0 monetary D D ac_ShareholderdesignatedContribution The amount of shareholder-designated contribution made during the period.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Increase Decrease In Accrued Income Taxes Payable us-gaap/2025 0 0 monetary D D Increase (Decrease) in Income Taxes Payable The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
Increase Decrease In Brokerage Receivables us-gaap/2025 0 0 monetary D C Increase (Decrease) in Receivable from Broker-Dealer and Clearing Organization The increase (decrease) during the reporting period in the total amount due to the entity related to activities and operations with other broker dealers, and clearing organizations, including deposits.
Increase Decrease In Due From Affiliates Current us-gaap/2025 0 0 monetary D C Increase (Decrease) in Due from Affiliates, Current The increase (decrease) during the reporting period in current receivables (due within one year or one operating cycle) to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership.
Increase Decrease In Payables To Broker Dealers us-gaap/2025 0 0 monetary D D Increase (Decrease) in Payable to Broker-Dealer and Clearing Organization The increase (decrease) during the reporting period in the aggregate amount of obligations incurred arising from transactions with broker-dealers, such as amounts due on margin and unsettled cash transactions; includes payables to brokers, dealers and clearing organizations.
Labor And Related Expense us-gaap/2025 0 0 monetary D D Labor and Related Expense Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Other Assets us-gaap/2025 0 0 monetary I D Other Assets Amount of assets classified as other.
Payments To Acquire Available For Sale Securities Debt us-gaap/2025 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Preferred Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Investment Advisory Fees Receivable 0001437749-25-015833 1 0 monetary I D Investment advisory fees receivable Carrying amount of fees receivable from providing investment advisory services.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Other Operating Assets us-gaap/2025 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Equity Method Investment Dividends Or Distributions us-gaap/2025 0 0 monetary D D Proceeds from Equity Method Investment, Distribution Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.
Financial Instruments Sold Not Yet Purchased At Fair Value us-gaap/2025 0 0 monetary I C Financial Instruments Sold, Not yet Purchased, at Fair Value Fair value of obligations incurred from short sales.
Increase Decrease In Employee Related Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Other Receivables us-gaap/2025 0 0 monetary I D Other Receivables Amount due from parties in nontrade transactions, classified as other.
Preferred Stock Shares Issued us-gaap/2025 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Restricted Cash And Cash Equivalents us-gaap/2025 0 0 monetary I D Restricted Cash and Cash Equivalent Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D D Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity Amount of expense (income); loss (gain); increase (decrease) in liability and (increase) decrease in asset used in operating activity; and cash inflow (outflow) from operating activity, classified as other; in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied.
Deferred Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Increase Decrease In Income Taxes Receivable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Income Taxes Receivable The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.
Investment Income Interest And Dividend us-gaap/2025 0 0 monetary D C Investment Income, Interest and Dividend Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.
Investment Owned At Fair Value us-gaap/2025 0 0 monetary I D Investment Owned, Fair Value Fair value of investment in security owned.
Nonoperating Income Expense us-gaap/2025 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2025 0 0 monetary I C Redeemable Noncontrolling Interest, Equity, Carrying Amount As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
Increase Decrease In Contributions To Partnerships 0001437749-25-015833 1 0 monetary D C ac_IncreaseDecreaseInContributionsToPartnerships The increase (decrease) in the contributions to partnerships during the reporting period.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Increase Decrease In Accounts Receivable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Equity Method Investments us-gaap/2025 0 0 monetary I D Equity Method Investments This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
Goodwill us-gaap/2025 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Interest Expense Nonoperating us-gaap/2025 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Payables To Broker Dealers And Clearing Organizations srt/2025 0 0 monetary I C Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization Amount payable to other broker-dealer and clearing organization, including, but not limited to, security failed-to-receive, deposit received for security loaned, open transaction, and floor-brokerage payable.
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Employee Related Liabilities Current And Noncurrent us-gaap/2025 0 0 monetary I C Employee-related Liabilities Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Gain Loss On Investments us-gaap/2025 0 0 monetary D C Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment.
Income Loss From Equity Method Investments us-gaap/2025 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Income Tax Receivable us-gaap/2025 0 0 monetary I D Income Taxes Receivable Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.
Increase Decrease In Accrued Liabilities And Other Operating Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Amount of increase (decrease) in accrued expenses, and obligations classified as other.
Interest Paid Net us-gaap/2025 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activity Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Other Operating Income Expense Net us-gaap/2025 0 0 monetary D C Other Operating Income (Expense), Net The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.
Payments To Minority Shareholders us-gaap/2025 0 0 monetary D C Payments to Noncontrolling Interests Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
Preferred Stock Shares Authorized us-gaap/2025 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2025 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 0 0 monetary D D Proceeds from Sale of Debt Securities, Available-for-Sale Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Treasury Stock Common Shares us-gaap/2025 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Treasury Stock Common Value us-gaap/2025 0 0 monetary I D Treasury Stock, Common, Value Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.
Treasury Stock Value Acquired Cost Method us-gaap/2025 0 0 monetary D D Treasury Stock, Value, Acquired, Cost Method Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Net Income Loss Including Portion Attributable To Noncontrolling Interests 0001437749-25-015833 1 0 monetary D C Net income The net income (loss) for the period, net of income taxes, including the portion attributable to the noncontrolling interests
Accrued Liabilities And Other Liabilities us-gaap/2025 0 0 monetary I C Accrued Liabilities and Other Liabilities Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Noncash Contribution Expense us-gaap/2025 0 0 monetary D D Noncash Contribution Expense Noncash charitable contributions made by the entity during the period.
Preferred Stock Value us-gaap/2025 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Taxes Paid Net us-gaap/2025 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Trading Securities Debt us-gaap/2025 0 0 monetary I D Debt Securities, Trading Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001437749-25-015833 2 13 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0001437749-25-015833 2 14 BS 0 H Trading Securities Debt us-gaap/2025 Trading - U.S. Treasury Bills 0
0001437749-25-015833 2 15 BS 0 H Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 Investments in equity securities (includes GAMCO stock with a fair value of $15,599 and $16,920, respectively) 0
0001437749-25-015833 2 16 BS 0 H Investment Owned At Fair Value us-gaap/2025 Investments in affiliated registered investment companies 0
0001437749-25-015833 2 17 BS 0 H Equity Method Investments us-gaap/2025 Investments in partnerships 0
0001437749-25-015833 2 18 BS 0 H Receivable From Brokerdealer And Clearing Organization Net Of Cash Withheld For Real Estate 0001437749-25-015833 Receivable from brokers 0
0001437749-25-015833 2 19 BS 0 H Investment Advisory Fees Receivable 0001437749-25-015833 Investment advisory fees receivable 0
0001437749-25-015833 2 20 BS 0 H Other Receivables us-gaap/2025 Receivable from affiliates 0
0001437749-25-015833 2 21 BS 0 H Income Tax Receivable us-gaap/2025 Income taxes receivable, including deferred tax assets, net 0
0001437749-25-015833 2 22 BS 0 H Goodwill us-gaap/2025 Goodwill 0
0001437749-25-015833 2 23 BS 0 H Other Assets us-gaap/2025 Other assets 0
0001437749-25-015833 2 24 BS 0 H Assets us-gaap/2025 Total assets 0
0001437749-25-015833 2 26 BS 0 H Payables To Broker Dealers And Clearing Organizations srt/2025 Payable to brokers 0
0001437749-25-015833 2 27 BS 0 H Employee Related Liabilities Current And Noncurrent us-gaap/2025 Compensation payable 0
0001437749-25-015833 2 28 BS 0 H Financial Instruments Sold Not Yet Purchased At Fair Value us-gaap/2025 Securities sold, not yet purchased 0
0001437749-25-015833 2 29 BS 0 H Accrued Liabilities And Other Liabilities us-gaap/2025 Accrued expenses and other liabilities 0
0001437749-25-015833 2 30 BS 0 H Liabilities us-gaap/2025 Total liabilities 0
0001437749-25-015833 2 31 BS 0 H Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2025 Redeemable noncontrolling interests 0
0001437749-25-015833 2 32 BS 0 H Commitments And Contingencies us-gaap/2025 Commitments and contingencies (Note 11) 0
0001437749-25-015833 2 34 BS 0 H Preferred Stock Value us-gaap/2025 Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding 0
0001437749-25-015833 2 35 BS 0 H Common Stock Value us-gaap/2025 Common Stock 0
0001437749-25-015833 2 36 BS 0 H Additional Paid In Capital us-gaap/2025 Additional paid-in capital 0
0001437749-25-015833 2 37 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Retained earnings 0
0001437749-25-015833 2 38 BS 0 H Treasury Stock Common Value us-gaap/2025 Treasury stock, at cost (4,446,699 and 4,407,681 shares, respectively) 1
0001437749-25-015833 2 39 BS 0 H Stockholders Equity us-gaap/2025 Total equity 0
0001437749-25-015833 2 40 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total liabilities, redeemable noncontrolling interests and equity 0
0001437749-25-015833 3 10 BS 1 H Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 Stock value 0
0001437749-25-015833 3 11 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2025 Preferred stock, par value (in dollars per share) 0
0001437749-25-015833 3 12 BS 1 H Preferred Stock Shares Authorized us-gaap/2025 Preferred stock, shares authorized (in shares) 0
0001437749-25-015833 3 13 BS 1 H Preferred Stock Shares Issued us-gaap/2025 Preferred stock, shares issued (in shares) 0
0001437749-25-015833 3 14 BS 1 H Preferred Stock Shares Outstanding us-gaap/2025 Preferred stock, shares outstanding (in shares) 0
0001437749-25-015833 3 15 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in dollars per share) 0
0001437749-25-015833 3 16 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares authorized (in shares) 0
0001437749-25-015833 3 17 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued (in shares) 0
0001437749-25-015833 3 18 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares outstanding (in shares) 0
0001437749-25-015833 3 19 BS 1 H Treasury Stock Common Shares us-gaap/2025 Treasury stock shares (in shares) 0
0001437749-25-015833 4 8 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2025 Total revenues 0
0001437749-25-015833 4 10 IS 0 H Labor And Related Expense us-gaap/2025 Compensation 0
0001437749-25-015833 4 11 IS 0 H Management Fee Expense us-gaap/2025 Management fee 0
0001437749-25-015833 4 12 IS 0 H Other Operating Income Expense Net us-gaap/2025 Other operating expenses 1
0001437749-25-015833 4 13 IS 0 H Operating Expenses us-gaap/2025 Total expenses 0
0001437749-25-015833 4 14 IS 0 H Operating Income Loss us-gaap/2025 Operating loss 0
0001437749-25-015833 4 16 IS 0 H Gain Loss On Investments us-gaap/2025 Gain (Loss) on Investments 0
0001437749-25-015833 4 17 IS 0 H Investment Income Interest And Dividend us-gaap/2025 Interest and dividend income 0
0001437749-25-015833 4 18 IS 0 H Interest Expense Nonoperating us-gaap/2025 Interest expense 1
0001437749-25-015833 4 19 IS 0 H Shareholderdesignated Contribution 0001437749-25-015833 Shareholder-designated contribution 1
0001437749-25-015833 4 20 IS 0 H Nonoperating Income Expense us-gaap/2025 Total other income, net 0
0001437749-25-015833 4 21 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 Income before income taxes 0
0001437749-25-015833 4 22 IS 0 H Income Tax Expense Benefit us-gaap/2025 Income tax expense 0
0001437749-25-015833 4 23 IS 0 H Profit Loss us-gaap/2025 Income before noncontrolling interests 0
0001437749-25-015833 4 24 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 Income attributable to noncontrolling interests 0
0001437749-25-015833 4 25 IS 0 H Net Income Loss us-gaap/2025 Net income attributable to Associated Capital Group, Inc.'s shareholders 0
0001437749-25-015833 4 27 IS 0 H Earnings Per Share Basic us-gaap/2025 Basic and Diluted EPS (in dollars per share) 0
0001437749-25-015833 4 29 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 Basic and diluted (in shares) 0
0001437749-25-015833 4 30 IS 0 H Common Stock Shares Outstanding us-gaap/2025 Total shares outstanding (in shares) 0
0001437749-25-015833 5 10 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Balance 0
0001437749-25-015833 5 11 EQ 0 H Minority Interest Decrease From Redemptions us-gaap/2025 Redemptions of noncontrolling interests 1
0001437749-25-015833 5 12 EQ 0 H Net Income Loss Including Portion Attributable To Noncontrolling Interests 0001437749-25-015833 Net income 0
0001437749-25-015833 5 13 EQ 0 H Treasury Stock Value Acquired Cost Method us-gaap/2025 Purchases of treasury stock 1
0001437749-25-015833 5 14 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Balance 0
0001437749-25-015833 6 8 CF 0 H Profit Loss us-gaap/2025 Net income 0
0001437749-25-015833 6 10 CF 0 H Income Loss From Equity Method Investments us-gaap/2025 Equity in net gains from partnerships 1
0001437749-25-015833 6 11 CF 0 H Depreciation Depletion And Amortization us-gaap/2025 Depreciation and amortization 0
0001437749-25-015833 6 12 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2025 Deferred income taxes 0
0001437749-25-015833 6 13 CF 0 H Noncash Contribution Expense us-gaap/2025 Donated securities 0
0001437749-25-015833 6 14 CF 0 H Debt And Equity Securities Unrealized Gain Loss us-gaap/2025 Unrealized gains on securities 1
0001437749-25-015833 6 15 CF 0 H Debt And Equity Securities Realized Gain Loss us-gaap/2025 Realized gains on sales of securities 1
0001437749-25-015833 6 17 CF 0 H Increase Decrease In Debt Securities Trading us-gaap/2025 Investments in trading securities 1
0001437749-25-015833 6 19 CF 0 H Increase Decrease In Contributions To Partnerships 0001437749-25-015833 Contributions to partnerships 1
0001437749-25-015833 6 20 CF 0 H Equity Method Investment Dividends Or Distributions us-gaap/2025 Distributions from partnerships 0
0001437749-25-015833 6 21 CF 0 H Increase Decrease In Due From Affiliates Current us-gaap/2025 Receivable from affiliates 1
0001437749-25-015833 6 22 CF 0 H Increase Decrease In Brokerage Receivables us-gaap/2025 Receivable from brokers 1
0001437749-25-015833 6 23 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2025 Investment advisory fees receivable 1
0001437749-25-015833 6 24 CF 0 H Increase Decrease In Income Taxes Receivable us-gaap/2025 Income taxes receivable 1
0001437749-25-015833 6 25 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2025 Other assets 1
0001437749-25-015833 6 27 CF 0 H Increase Decrease In Payables To Broker Dealers us-gaap/2025 Payable to brokers 0
0001437749-25-015833 6 28 CF 0 H Increase Decrease In Accrued Income Taxes Payable us-gaap/2025 Income taxes payable 0
0001437749-25-015833 6 29 CF 0 H Increase Decrease In Employee Related Liabilities us-gaap/2025 Compensation payable 0
0001437749-25-015833 6 30 CF 0 H Increase Decrease In Accrued Liabilities And Other Operating Liabilities us-gaap/2025 Accrued expenses and other liabilities 0
0001437749-25-015833 6 31 CF 0 H Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities us-gaap/2025 Total adjustments 0
0001437749-25-015833 6 32 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash used in operating activities 0
0001437749-25-015833 6 34 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2025 Purchases of securities 1
0001437749-25-015833 6 35 CF 0 H Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 Proceeds from sales of securities 0
0001437749-25-015833 6 36 CF 0 H Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2025 Return of capital on securities 0
0001437749-25-015833 6 37 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net provided by/(used in) investing activities 0
0001437749-25-015833 6 39 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2025 Purchases of treasury stock 1
0001437749-25-015833 6 40 CF 0 H Payments To Minority Shareholders us-gaap/2025 Redemptions of redeemable noncontrolling interests 1
0001437749-25-015833 6 41 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash used in financing activities 0
0001437749-25-015833 6 42 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 Net decrease in cash, cash equivalents and restricted cash 0
0001437749-25-015833 6 43 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 Cash, cash equivalents and restricted cash at beginning of period 0
0001437749-25-015833 6 44 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 Cash, cash equivalents and restricted cash at end of period 0
0001437749-25-015833 6 46 CF 0 H Interest Paid Net us-gaap/2025 Cash paid for interest 0
0001437749-25-015833 6 47 CF 0 H Income Taxes Paid Net us-gaap/2025 Cash paid for taxes 0
0001437749-25-015833 6 49 CF 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0001437749-25-015833 6 50 CF 0 H Restricted Cash And Cash Equivalents us-gaap/2025 Restricted cash included in receivable from brokers 0
0001437749-25-015833 6 51 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash, cash equivalents and restricted cash 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.